17-8313250-A-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP4_StrongBP6_ModerateBP7BS2
The NM_173728.4(ARHGEF15):c.930A>G(p.Gln310Gln) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000432 in 1,604,224 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.00029 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00045 ( 7 hom. )
Consequence
ARHGEF15
NM_173728.4 synonymous
NM_173728.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0200
Publications
2 publications found
Genes affected
ARHGEF15 (HGNC:15590): (Rho guanine nucleotide exchange factor 15) Rho GTPases play a fundamental role in numerous cellular processes that are initiated by extracellular stimuli that work through G protein-coupled receptors. This gene encodes a protein that functions as a specific guanine nucleotide exchange factor for RhoA. It also interacts with ephrin A4 in vascular smooth muscle cells. Two alternatively spliced transcripts variants that encode the same protein have been found for this gene. [provided by RefSeq, Aug 2010]
ARHGEF15 Gene-Disease associations (from GenCC):
- genetic developmental and epileptic encephalopathyInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- schizophreniaInheritance: Unknown Classification: NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -11 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.61).
BP6
Variant 17-8313250-A-G is Benign according to our data. Variant chr17-8313250-A-G is described in ClinVar as Benign. ClinVar VariationId is 461442.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-0.02 with no splicing effect.
BS2
High AC in GnomAd4 at 44 Unknown,AD gene.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ARHGEF15 | NM_173728.4 | c.930A>G | p.Gln310Gln | synonymous_variant | Exon 3 of 16 | ENST00000361926.8 | NP_776089.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000296 AC: 45AN: 152218Hom.: 1 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
45
AN:
152218
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000764 AC: 185AN: 242294 AF XY: 0.000706 show subpopulations
GnomAD2 exomes
AF:
AC:
185
AN:
242294
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000447 AC: 649AN: 1451888Hom.: 7 Cov.: 34 AF XY: 0.000465 AC XY: 336AN XY: 722580 show subpopulations
GnomAD4 exome
AF:
AC:
649
AN:
1451888
Hom.:
Cov.:
34
AF XY:
AC XY:
336
AN XY:
722580
show subpopulations
African (AFR)
AF:
AC:
0
AN:
33472
American (AMR)
AF:
AC:
3
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
26084
East Asian (EAS)
AF:
AC:
566
AN:
39690
South Asian (SAS)
AF:
AC:
57
AN:
86210
European-Finnish (FIN)
AF:
AC:
0
AN:
43986
Middle Eastern (MID)
AF:
AC:
0
AN:
5764
European-Non Finnish (NFE)
AF:
AC:
3
AN:
1111648
Other (OTH)
AF:
AC:
20
AN:
60322
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
46
92
138
184
230
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000289 AC: 44AN: 152336Hom.: 1 Cov.: 32 AF XY: 0.000282 AC XY: 21AN XY: 74486 show subpopulations
GnomAD4 genome
AF:
AC:
44
AN:
152336
Hom.:
Cov.:
32
AF XY:
AC XY:
21
AN XY:
74486
show subpopulations
African (AFR)
AF:
AC:
0
AN:
41578
American (AMR)
AF:
AC:
0
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
43
AN:
5180
South Asian (SAS)
AF:
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
1
AN:
68030
Other (OTH)
AF:
AC:
0
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.515
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
5
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Developmental and epileptic encephalopathy Benign:1
Dec 24, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.